NADPH oxidases are the major source of intracellular ROS generation. NADPH oxidase inhibitors should decrease ROS generation but they have been shown to increase ROS generation.
As Goodwin suggested, KRAS and other survival signal pathways might be activated. If that is the case, metabolic activation causes accumulation of ROS.